E, We are just one week away from the Fierce Launch Readiness for Medical Affairs and Communications Teams Forum - a two-day free virtual event on Nov. 30 - Dec 1, 2022! Secure your virtual seat today to join leading experts from AstraZeneca, Bristol Myers Squibb, Genentech, Pfizer, Takeda, and moreas they exchange best practices and insights that are essential to successfully launching a product in today’s complex healthcare landscape. You won’t want to miss this unique opportunity! |
|
|
*All registrants will have on-demand access to the event for up to six months! Be sure to register now, even if you can’t attend all of the sessions live. |
|
|
ANNOUNCING OUR CHAIRPERSON |
|
|
| Narinder Bhalla, MD Senior VP, Head of World-Wide Medical, Cardiovascular & Established Brands Bristol Myers Squibb |
| |
|
Rav Seeruthun, MRCGP, MBA VP US Medical Affairs Genentech |
| Monica De Abadal, MD, MBA Senior VP, Head of Medical Affairs North America Ipsen |
| Deborah Long, MD Senior VP Medical Affairs Vertex |
|
|
Roula Qaqish, PharmD Franchise Head, US Medical Affairs, Women’s Cancers AstraZeneca |
| Tamira Sperling Director, Medical Affairs Multichannel MedComms Regeneron |
| Kirk Shepard, MD Chief Medical Officer & Senior VP, Head of Global Medical Affairs OBG Eisai |
|
|
Sagar Shah, PharmD Global Lead, Oncology Field Medical Excellence Pfizer |
| Zsuzsanna Devecseri, MD, MBA VP, Head of Global Oncology Medical Affairs Sanofi |
| Luca Dezzani, MD VP US Oncology Medical Affairs Johnson & Johnson |
|
|
THANK YOU TO OUR 2022 PARTNERS |
|
|
If you no longer wish to receive promotion on this event, simply unsubscribe.
Refer to our Privacy Policy.
Fierce Life Sciences is a division of Questex LLC.
685 3rd Ave 21st Floor New York, NY 10017 Contact Us
© 2022 Questex LLC. All Rights Reserved.
Reproduction in whole or in part is prohibited without written permission. |
|
|
|
